Dr. Daniel Tanaka

Thoracic medical oncologist · Policlinico Gemelli · Italy (IT) · Oncology

Tier 3STK-0001GoodOwner MSL JWJames Whitfield

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: Elderly patientsPD-L1 biomarkers
Engagement preference: In person
Advisory boards: 1
Publications: 13
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 3: 1 per year (assumption)

Last engaged: 22 Jun 2026 (85 days ago)
Next planned contact: 22 Jun 2027
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
22 Jun 2026	Investigator meeting	Virtual	James Whitfield	Vantrexa	Comparator checkpoint monotherapyInfusion-reaction management	0	—	Reviewed	ENG-0015
18 Jan 2026	Payer / HTA meeting	Virtual	James Whitfield	Vantrexa	Comparator checkpoint monotherapy	0	—	Reviewed	ENG-0084

Timeline

22 Jun 2026
Investigator meeting
Comparator checkpoint monotherapy, Infusion-reaction management
18 Jan 2026
Payer / HTA meeting
Comparator checkpoint monotherapy

Related stakeholders (5)

Policlinico Gemelli

Dr. Sven Abbott
Thoracic medical oncologist
Tier 2
Dr. Zoë Yamamoto
Thoracic medical oncologist
Tier 1
Dr. Tomoko Vogel
Radiation oncologist
Tier 2
Dr. Ingrid Dubois
General neurologist
Tier 3
Dr. Quentin Eriksen
Headache specialist
Tier 3